
Duchenne, gene therapy tests for muscular dystrophy in 2 years
A new gene therapy for Duchenne shows promising results in mice, reversing muscle damage. Human trials expected within two years.
A new gene therapy for Duchenne shows promising results in mice, reversing muscle damage. Human trials expected within two years.
The natural compound Urolithin A achieves excellent results in Duchenne muscular dystrophy in mice. We await those of human tests.
News about the world of tomorrow.
We give news about the future of technology, science and society: if there is one thing that is about to arrive, it has already arrived here.
Category
Language editions
fffdddddd
To provide the best experiences, we and our partners use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and to show (non-)personalized ads. Not consenting or withdrawing consent may adversely affect some features and functions.
Click below to agree to the above or to make detailed choices. Your choices will apply only to this site. You can change your settings at any time, including withdrawing your consent, by using the Cookie Policy buttons or by clicking the manage consent button at the bottom of the screen.